Post by
Red~One on May 17, 2022 9:39am
RE:RE:Broken News
n the 3rd last Sedar News Release (does Farewell get a discount for using Sedar to exclusively handle his News?)
Bob mentions :" .... had to make the difficult decision to use funds earlier earmarked for the balance of the audit fee to be allocated instead for research and development expenses for the Company’s ongoing Phase 1 clinical study in Australia. If it had not done so it would have faced research and development delays."
He also lists an email address that doesn't work.
Questions:
At what point is he in the Phase 1 study?
Why list a phony email address?
Has anyone tried to phone him? On SEDAR it's "888-861-2008"
Paid insiders need not reply to these questions since they......well we know why by now .